1. "Depart from evil, and do good": Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pancreatic cancer. (May 2022) Authors: Comandatore, Annalisa; Balsano, Rita; Immordino, Benoit; Arguedas, Davinia; Capula, Mjriam; Baglio, Serena R.; Garajovà, Ingrid; Malapelle, Umberto; Morelli, Luca; Giovannetti, Elisa Journal: Critical reviews in oncology/hematology Issue: Volume 173(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-92 GPS as a prognostic index and a predictor of toxicity in early or locally advanced head and neck cancer patients treated with radiotherapy or definitive chemoradiotherapy. (July 2021) Authors: Bui, Simona; Pietri, Elisabetta; de Corianò, Matil; Luca, Isella; Mazzaschi, Giulia; Tommasi, Chiara; Garajovà, Ingrid; Grondelli, Claudia Journal: Oral oncology Issue: Volume 118(2021)Supplement Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases. Issue 1 (26th June 2018) Authors: Brandi, Giovanni; Venturi, Michela; De Lorenzo, Stefania; Garuti, Francesca; Frega, Giorgio; Palloni, Andrea; Garajovà, Ingrid; Abbati, Francesca; Saccoccio, Gioconda; Golfieri, Rita; Pantaleo, Maria Abbondanza; Barbera, Maria Aurelia Journal: Cancer communications Issue: Volume 38:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗